Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Gross Profit (2018 - 2025)

TELA Bio has reported Gross Profit over the past 8 years, most recently at $13.8 million for Q4 2025.

  • Quarterly results put Gross Profit at $13.8 million for Q4 2025, up 22.58% from a year ago — trailing twelve months through Dec 2025 was $54.3 million (up 16.89% YoY), and the annual figure for FY2025 was $54.3 million, up 16.89%.
  • Gross Profit for Q4 2025 was $13.8 million at TELA Bio, down from $14.0 million in the prior quarter.
  • Over the last five years, Gross Profit for TELA hit a ceiling of $14.1 million in Q2 2025 and a floor of $3.5 million in Q1 2021.
  • Median Gross Profit over the past 5 years was $10.3 million (2023), compared with a mean of $9.3 million.
  • Biggest five-year swings in Gross Profit: soared 143.98% in 2021 and later fell 3.47% in 2024.
  • TELA Bio's Gross Profit stood at $5.7 million in 2021, then soared by 44.48% to $8.2 million in 2022, then surged by 42.17% to $11.6 million in 2023, then dropped by 3.47% to $11.2 million in 2024, then rose by 22.58% to $13.8 million in 2025.
  • The last three reported values for Gross Profit were $13.8 million (Q4 2025), $14.0 million (Q3 2025), and $14.1 million (Q2 2025) per Business Quant data.